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A limited clinical pilot study involving an amalgam of specialized disciplines including neurology, neuropharmacology, 
neuropsychology, neurosurgery, ncuroanesthesia, neuroradiology, surgical pathology, neuropathology, and urological 
surgery was organized to clarify issues related to patient selection, optimization o f grafting materials, design of a safe, 
effective, standardized, and reproducible surgical technique, and possible modification of clinical patterns. After initial 
assessment of 82 Parkinsonian patients for periods of 6 to 20 months, 10 (age. 39-68 years) were selected for unilateral 
or bilateral adrenomedullary autografts to the caudate nucleus with ependymal and cerebrospinal fluid contact, 
employing imagc-direeted stereotactic methods. Selection was made only after clear definition of clinical pattern and 
optimization o f medication responses. Adrenal glands were harvested by a retroperitoneal approach (mean estimated 
blood loss <  75 ml). Care was taken to maximize the graft content o f medullary tissue. Stereotactic methods afforded 
standardized, reproducible, precise targeting and transit trajectory with unilateral or bilateral placement of materials 
within the striatum (tissue volume, 80 m m ’) with access to the ventricular fluid of the frontal horn. Considerable 
variability in satisfactory donor medullary tissue was encountered. One patient did not undergo grafting because of 
unsatisfactory medullary tissue. No significant surgical complications were noted and all patients were ready for 
discharge 7 days after surgery. One patient who manifested no apparent clinical change died 6 weeks after bilateral 
grafting of unrelated causes during a lithotripsy procedure. Postmortem examination disclosed precise graft placement 
with a paucity of structurally preserved medullary cells. Postoperative observations, including parameters of clinical 
observation, medication schedules and records, patient and family commentaries, and imaging studies (computed 
tomograms and single photon emission computed tomograms), have been made for periods from 16 to 20 months. 
Sustained improvement in preexisting clinical patterns and reduction in drug requirements were observed in 4 of 8 
patients. No increased benefit could be ascribed to bilateral graft placement. These observations would indicate a 
primary role for stereotactic methodology for cerebral graft placement, as it affords a minimally invasive but precise, 
safe, and reproducible surgical method. In addition, the clinical observations indicate favorable alterations in the 
established pattern of the disorder, which would justify further cautious exploration of alternate donor sources or 
refinements of biological graft site manipulations. {.Neurosurgery 26:746-757, 1990)
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INT RODUCTION
The prospect for restoration o f cerebral function through 
grafting has initiated both excitement and skepticism for more 
than half a century (3. 15. 40. 46). The culmination of a 
number of scientific developments over the past two decades 
have provided increased impetus and plausibility to the clin­
ical application of this concept (1, 5, 14, 18-23, 33. 47, and 
Backlund E-O. personal communication, April 1989). Based 
on over 90 years of periodic laboratory observations and 
increased sophistication in areas of immunohistology, exper­
imental models, and molecular biochemistry, initial steps 
were undertaken in Sweden, and two Parkinsonian humans 
received stereotactically placed adrenal medullary autografts 
resulting in modest transient alterations in their clinical 
courses (4). Subsequently, Mexican investigators employing 
an open technique published more dramatic and sustained 
alterations of Parkinsonian syndromes in a small series of 
younger patients (34). These publications provided the im ­
petus for the initiation of the studies transmitted in this report. 
While clinical investigations are underway in this important 
area, with several early clinical studies having been reported, 
a number of issues require further clarification, including
those related to patient selection, optimization of surgical 
techniques, defining and reducing surgical complications, pro­
cedural impact on established clinical courses, type and vol­
ume of grafted material, graft viability, and expectations of 
any procedure (4. 6. 24. 32. 35, and personal communica­
tions: Backlund F.-O, April 1989, and Madra^o I, April 1989). 
This report presents observations in a modes! number of 
patients in an effort to add further perspective and definition 
to this complex and largely ill-defined area of studv (27, 30, 
36.40-43). '
M ETHODS A N D  RATIONALE
Genentl considerations and study design
W ith consideration o f the multitude of difficulties attendant on 
the development of any clinical study, but. in particular, one as 
complex and variable as Parkinson's disease, il was considered that 
strict definition of' the preoperative patient clinical paLlems was 
essential. Therefore, the initial objective of the study was to identify 
a group of patients in whom a clinical pattern was clearly established, 
with absolute optim ization of the medication response.
Second, a standardized, precise, and reproducible operation was
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devised that would reduce the variables attendant on the surgical 
procedure. Strict observation postoperatively for alteration of estab­
lished clinical patterns was the final part of the protocol.
A study group was assembled comprised of members of the follow­
ing divisions and departments: neurological surgery, neurology, neu­
ropharmacology. neuropsychology, neuroradiology, neuroanesthesia, 
urology, surgical pathology and neuropathology.
Patient selection
After consideration of available data and study goals, criteria for 
inclusion in the study were established. These were as follows:
1. An unsatisfactory response to medical management with either 
significant disease progression, unsatisfactory side effects, or 
complications o f drug administration.
2. A problem with response to dopamine.
3. Good general health.
4. No clinical evidence of dementia.
5. A well-established and relatively predictable clinical pattern.
6. A psychosocially stable individual and family.
7. The presence o f bilateral adrenal glands on imaging studies.
8. No significant cerebral atrophy on imaging studies.
Preoperative evaluation
Patients were evaluated for 6 months with recording of “on" and 
“off' functional ratings according to the Hoehn and Yahr scale (25) 
as well as the Unified Rating Scale for Parkinson’s disease (IJRSP) 
(29). Evaluations were conducted with care to ensure uniformity of 
time of day. time elapsed since administration o f medication, and 
other recognized variables in the evaluation o f Parkinsonian syn­
dromes. The URSP is a 4-point scale that consists of the following 
subcategories: 1) mentation, behavior and mood; 2) activities of daily 
living; 3) motor examination: and 4) complications of therapy. The 
Hoehn and Yahr scale stages the severity of Parkinsonism, with 0 
being no sign of disease and 5 being wheelchair-bound or bedridden. 
For the purposes of this study, motor examination scores that repre­
sented a defined objective performance measure of 14 individual 
parameters were totalled and the results of 2 to 3 visits averaged lo 
provide a mean motor score. “O f f '  can be defined as status prior to 
the first morning dose or at the end of the dose. Scores were obtained 
in “on” and “off' conditions. “O n "  represented the peak dose effect 
and “off' data was at the end o f dose assessment. Strict recording of 
medication dosages and schedules were made. Efforts were made to 
optimize medication schedules during this period.
Individuals who were considered to be candidates for grafting 
underwent formal neuropsychological assessment that included the 
Wechsler Adult Intelligence Scale-Revised, the Mini-Mental Status 
Examination, the Wechsler Memory Scale, grocery list learning, the 
Minnesota Paper Form Board, the Purdue Pegboard, finger lapping, 
star tracing and reaction time tasks. Imaging assessments included 
magnetic resonance imaging (M R I). computed tomography (CT), 
and single photon emission computed tomography (SPECT). A video 
tape record of “on" and "ofF  function was made for all patients. A 
record of lumbar fluid examination for catecholamines and metabo­
lites was also kept for all patients. The purpose o f videotape recording 
was to document pre- and postoperative clinical findings in relation 
to time and dose o f medication. A specific examination protocol was 
followed.
Surgical procedure
Genera! Method. The objectives of the procedure were to place a 
viable adrenal medullary autograft o f consistent volume in an appro­
priate brain region with m in im um  risk to the patient and m in im iza­
tion of ancillary neural trauma that could effect clinical observations.
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Therefore, an image-directed stereotactic method was adopted (2). 
The stereotactic method offered the advantage of standardization of 
experimentation with reproducibility o f targeting and tissue place­
ment in consecutivc patients. Additionally, because craniotomy was 
not performed, overall operative trauma was m inim ized. Therefore, 
harvesting o f the patient's adrenal gland, even by a retroperitoneal 
approach (deemed optimal by our genitourinary surgeons) constituted 
the major operative procedure in these physiologically impaired 
patients.
Graft. A key objective was to deliver a viable graft of maximum 
medullary content. In preparation, cadaver adrenals were dissected 
by members o f the surgical team and examined by a pathologist lo 
gain experience in harvesting methods and definition of adrenal 
medullary cells. At surgery, glands were immersed in Eagle's m in i­
m um  essential medium at 42°F and sectioned in 3-mm slices in 
“bread-loaf" fashion. Individual slices were dissected in chilled Eagle’s 
m in im um  essential medium under the operating microscope, and 
fragments were evaluated by the pathologist al frequent intervals. A 
delivery device was developed that allowed placement o f a reproduc­
ible volume o f tissue in consecutive patients. This consisted o f a 
surgical stainless steel coil (Radionics. Inc., Burlington. Massachu­
setts) measuring 2.5 m m  in diameter and 20 m m  in length (100 m m ’) 
that could be loaded with medullary fragments after microscopic 
dissection and histological assessment. The volume of the coil was 
arbitrarily selected to double that described by Backlund et al. in 
their initial studies (4). During pathological assessment, care was 
taken to m inim ize the introduction o f cortical tissue, which has been 
demonstrated to affect plasticity toward neuronal morphology (12,
13, 48). Estimated purity was considered to reach 90% with patho­
logical review, and 10 to 15 fragments o f medullary tissue were loaded 
into the coil by microscopic technique.
Procedure. In consideration o f available data and experiences with 
the open surgical technique introduced by Madrazo et al. (34) the 
caudate head was selected as the target for grafting within the striatum. 
This target was selected in spite of data suggesting some advantage 
for placement in the putamen, since caudate targeting allowed epen­
dymal and cerebrospinal fluid contact (26. 28, 39, 45, 46). Image- 
directed stereotactic methods employing either a Brown-Roberts- 
Wells (BRW ) (2) or Cosman-Roberls-Wells (CRW ) (11) stereotactic 
system allowed for placement of the graft delivery device in the 
caudate head and adjacent striatum in a reproducible fashion with 
approximately 16 m m  o f the device within the striatal parenchyma 
o f the caudate head and 4 m m  in the ventricular fluid of the frontal 
horn. Therefore, approximately 80 m m ' of medullary tissue was 
placed within the parenchyma. Transits and trajectories were prede­
termined by imaging reconstructive methods. To m inim ize trauma 
further, only a 0.25-inch twist drill entry was required. Tissue delivery 
was performed through a graduated cannula system once initial 
penetration o f the caudate striatum had been achieved in the line of 
trajectory of the graft. W ith this method, unilateral or bilateral grafting 
could be achieved within 3.5 hours of the initiation of the entire 
procedure. It was considered that m inim ization o f lime from har­
vesting the adrenal to graft placement should be achieved: however, 
proper dissection and verification o f tissue required a m in im um  of 
45 minutes, during which other members o f the surgical team pre­
pared stereotactic transit trajectories and instrumentation for imme­
diate placement once dissection, verification, and loading of the 
device were completed. In general, whether grafting was undertaken 
in a unilateral or a bilateral technique, the completion time from 
harvesting to grafting was less than 1 hour (Table 1).
Postoperative Management and Evaluation. In the immediate post­
operative period, patients were transferred to the neurosurgical inten­
sive care unit. At that time, initial clinical observations were begun 
by the neurologists on the study team. In an effort to reduce problems 
associated with decreases in patient mobility and other neurological 
dysfunction that could preclude a successful and uncomplicated 
recovery, medications were initiated immediately in the postoperative
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period, with adjustments being made as recovery progressed. Thu 
following evaluations w ere carried out:
1. Clinicalevuiiiuikm. The assessments— performed weekly for the 
first month and thereafter at monthly intervals— included the 
URSP. the Hoehn and Yahr scale, the Schwab and F.ngland 
scale, medication schedules, patient communications and famil> 
communications. Care was taken to assure that assessments 
were undertaken during uniformly defined periods with respect 
to time o f day and medication administration, Videoiape as­
sessment was conducted at 3-month intervals. Patients were 
evaluated at a defined time before and after their medication oil 
each visit. It was decided that clinically improved status could 
be conferred on those individuals who satisfied the following 
criteria 12 months after surgery: a> a sustained reduction of 
preoperative medication requirements; h) a sustained improve­
ment in mean motor score (URSP): and c> a subjective impres­
sion of improvement.
2. Imaging studies. These included CT and SPFCT at intervals of
1, 3, 6. and 12 months.
3. Cerebrospinal fluid examination. Cerebrospinal lluid from lum ­
bar sampling was examined first at I week and then at 4. 12. 
and 24 weeks. Examination included assays of homovanillic 
acid, 5-hyroxy-indolcacctic acid, and 3-mclhoxy-4-hydroxy 
phenylethylene glycol (15).
T/vblk 1
Adrenomedullwy-Siricual Amograft: Stereotactic Technique
Time Required 
(m in)
1. Apply base ring (local) 10
2. Scan for target(s) 10
3. Determine transits 10
4. Intubation/prone positioning 30
5. Adrenalectomy (L) (retroperitoneal) 60
6. G land dissection 60
7. Stereotactic grafting" 30
Total time required: ±3 h 30 m in
0 See Reference 2.
CASE MATERIAL AND OPERATIVE 
OBSERVATIONS
PopuUttiim profile
After 82 Parkinsonian patients underwent initial assess- 
meat for periods o f 6 to 20 months throughout a 24-month 
period. 10 patients were selected who were felt to meet the 
criteria for inclusion (Table 2). This group included 6 men 
and 4 women who ranged in age from 39 to 68 years (mean. 
53 years). The mean duration o f disease was 10.9 years, with 
a range of 6 to 17 years, The rating on the Hoehn and Yahr 
scale ranged from 2 to 4. with a mean o f 3 while "on" and a 
mean of 2 to 5 while "off.” The mean dose of levodopa 
(Sinemet. Merck Sharp & Dohmc. West Point. Pennsylvania) 
was 825 mg per day. with a range of 700 to 1250 mg per day. 
All patients had had frequent increases in their dose o fthe 
drug and severe side effects from medications. At the time of 
surgery, 3 patients were using bromocriptine (Patients 5-7) at 
an average dose o f I 5 mg. All the patients except one (Patient 
1) had in tlte past experienced either no benefit or troublesome 
side effects when given a trial of bromocriptine. One patient 
had been treated with pergolide and took amitriptyline for 
sleep (Patient 9), The protocol established that the first 5 
patients would be treated with unilateral grafts and the second 
5 with bilateral grafts.
OjH-niiive priKvdurt's
Surgical procedures were undertaken during a 12-month 
period (July 1987 to June 1988). Adrenal harvesting was 
uneventful, with a mean blood loss of 75 ml (range, 25-150 
ml); however, at dissection, 2 o f the 10 glands were observed 
to have hemorrhage in the medullary region, which made 
identification of graft material difficult. O f  importance, con­
siderable variability was noted in the volume of medullary 
tissue available for the graft (Table 2). In one case, no graft 
was undertaken because the combination of hemorrhage and 
paucity of available material precluded grafting. Stereotactic 
placement was uneventful, with successful placement 
achieved unilaterally in 5 patients and bilaterally in 4 (Figs. 1
Taui.h 2
Adrenomedullary-Strialal Auiogmji: Clinical Data
Patient Sex" Age;’
Duration 












Tissue (m m )'
Graft" Complications Outcome1
1 M 43 9 B. R, P 3 7(10 7/87 3 ' I 0 Nonresponder
2 F 39 8 T. B, R , P 3 1000 8/87 4‘ R Vivid dreams Responder
3 .M 57 13 T. R 2 1250 9/87 3* R 0 Responder
4 F 49 5 (R) R. T. B 2 750 11/87 3* R 0 Non responder
5 M 44 1 1 R, B, P 3 500 1 1/87 4r R. L 0 Responder
6 M 65 8 B, R. P 4 1000 12/87 (H )2- R Psychosis Responder
7 M 68 17 R. B 3 1250 2/88 (H) r 0 ’ 0 Non responder
8 F 58 12 R. B 3 500 5/8X 44 R. L 0 Non responder
9 F 60 15 R, B, T 3 800 5/88 2* R. L 0 Non responder
10 M 50 1 1 B, R 4 500 6/88 l + R. L 0 Death (6 Wks)
° Total: 6 men, 4 women.
* Average: 53 years.
‘ Average: 10.5 years.
J B. bradykinesia. R. rigidity. P. postural instability: T. tremor: (R). right-sided. Profile listed in order of severity, 
' Hoehn and Yahr scale. Average rating. 3.
'Daily  requirement of i.-Dopa. Average. 825 mg,
* W idth of medullary ribbon of available donor tissue on sections. (H), hemorrhage. 
h Site of graft: L. left striatum: R. right striatum: 0. none.
‘ Status at 1 year after surgery,
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Fig. I. Lateral (.1) and posteroanierior <B) radiographs demon­
strating bilateral coil position.
and 2). Because of the impressive character o f bilateral clinical 
findings, the fifth patient was treated with bilateral caudatc 
grafts. All procedures were concluded in a total of 3.5 to 4 
hours of operating time, and the time from adrenal harvesting 
to graft placement never exceeded I hour. No unusual intra- 
operativc events were encountered.
OPERATIVE COM PLICAT IONS
No threatening complications occurred in the early post­
operative period (Table 2). One elderly patient suffered 48 
hours o f hallucinatory experiences: however, he was dis­
charged from the intensive care unit at 72 hours and was 
subsequently discharged from the hospital at 10 days. Emer­
gence from anesthesia was uneventful in all patients: no 
unusual alteration in analgesic requirement was noted by the 
urological team.
OBSERVATIONS
O f the 10 patients enrolled in the protocol. 1 had an 
adrenalectomy without grafting and I died 6 weeks after 
surgery during general anesthesia for a lithotripsy procedure, 
leaving S patients with postoperative follow-up ranging from 
16 to 20 months.
Clinical patterns I Entire patient group
When all the patients are considered as a group, they appear 
to demonstrate a modest reduction in medication require­
ments and improvement in motor function from 3 to 5 
months after surgery. This initial response was followed by 
an apparent stabilization of medication requirements at levels 
not significantly difi'ereni from preoperative levels. Motor 
function appeared to deteriorate slightly from 8 to 12 months 
after surgery, but the patients followed up for 16 to 20 months 
demonstrated persistent improvements in motor scores on 
the average of 30 to 40% (Fig. 3).
Fit;. 2. Computed tomogram demonstrating coil position in the caudaie-striatum ( -I and li) and fronial horn (C) on successive 5-ram slices.




a Months 3-5 Months 8-12 Months 16-20 Mcnthg 
TIME AR ER SURGERY
F ig . 3. Medication requirements and motor scores for all patients 
after surgery.
Clinical patterns B: Nonresponders (no sustained 
improvement)
When the patients are stratified into responders and non­
responders, postoperative changes become more striking than 
when the group is considered as a whole. Figure 4 illustrates 
the trends in medication requirements and motor function in 
the nonresponder patients. While medication requirements 
remained unchanged after surgery, an improvement in motor 
function was observed 3 to 5 months after surgery; however, 
a return to baseline levels was seen at approximately 12 
months. The one nonresponder whose progress was followed 
out to 20 months after surgery is slightly worse compared 
with his baseline motor score.
Clinical patterns C: Responders {sustained improvement)
The responder group demonstrated progressive persistent 
reduction in medication requirements up to 16 to 20 months 
after surgery. The rate of reduction in medication was most 
marked during the first 3 to 5 months after surgery, and then 
remained at approximately two-thirds of the preopcrative 
dosage for the next 12 months.
Motor scores while “on" improved, with peak improvement 
occurring at 8 to 12 months. As the follow-up period extended 
to 16 to 20 months, the paiients showed a trend toward 
baseline motor function, but still demonstrated approximately 
one-third less motor disability as compared with the baseline 
level (Fig. 5). No change in motor scores while “ofl" was 
observed.
Clinked patterns D: Responders versus nonresponders
Figures 6 and 7 emphasize the two apparently distinct 
patterns of response to the grafting procedure observed in 
responders and nonresponders. Nonrcsponders demonstrated 
an insignificant reduction medication requirements at 3 to 5 
months after surgery, followed by progressive escalation in 
medication requirements from 5 to 20 months. Responders, 
in contrast, showed the opposite pattern, with sustained re­
duction in medication requirements up to 20 months after 
surgery (Fig. 6).
The motor scores of both groups while “on” improved 
during the 3- to 5-month postoperative period. Nonresponder 
patients, however, returned to baseline by 12 months after 
surgery, while responders showed persistent improvement up 
to 20 months {Fig. 7).
floL’hn and Ytthr ratings





Fk.;. 4. Nonrcsponder group. Transient improvement in the m o­
tor score is followed by a return to  ilic baseline.
TIME AFTER SURGERY
Fk ;. 5. Responder group. Reduction in medication parallels im ­
proved motor scores during the lirst 12 m onihs after surgery.
TIME AFTER SURGERY
Fk ;. 6. Patterns o f medication requirements after surgery; Re­
sponders versus nonresponders.
Percentage of time "off"
One patient experienced a significant (50%) reduction in 
the percentage of time "off" at 6 months after surgery, but 
then deteriorated somewhat at 12 months. Two nonrespondcr 
patients (Patients 1 and 9) had modest reductions in time 
"off" (25%). while the other two nonresponder patients (Pa­
tients 4 and 8) had increases in time "off."' The remaining 3 
patients (all responders) were unchanged with respeel to time 
"'off- (Table 3).
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TIME AFTER SURGERY 
Fig. 7. Patterns o f motor response after surgery: Responders ver­
sus nonresponders.
Ta b u ; 3 
Percentage of Time "Off"
Patient
Preoperative 
Time "O f f ’ (%)
Postoperative Time “O ff” 
(%)
(6 Months) (12 Months)
1 26-50 1-25 1-25
2 76-100 1-25 1-25
3 1-25 1-25 1-25
4 1-25 26-50 26-50
5 1-25 1-25 1-25
6 1-25 1-25 26-50
7 NA
8 1-25 26-50 26-50
9 25-50 1-25 1-25
10 Died
“ As measured by the Unified Rating Scale for Parkinson's disease.
Patient impressions
A summary of patient impressions of their overall response 
to the surgery 1 year later is shown in Table 4. Patients who 
were considered improved presented a sustained impression 
of a sense of improved function that correlated with objective 
motor findings and reduction in medication requirements.
Predictive factors: Response versus nonresponse
In attempting to determine whether responders and non­
responders could be differentiated preoperatively. a number 
of variables were compared between the two groups, including 
age. duration of disease, Hoehn and Yahr rating, medication 
requirements. UPRS motor score, percentage of time “off,” 
and quality of the adrenal gland. There were no significant 
differences in any of these categories, with the exception of 
preoperative medication. Nonresponders were receiving less 
preopcrative medication than responders (Table 5).
Unilateral versus bilateral grafting
Although the number of cases was small, no trend indicat­
ing an advantage to bilateral grafting was found. In fact, 
unilateral grafting demonstrated a higher success rate (60%) 
than bilateral grafting (33%). In order to rule out preoperative 
factors accounting for this difference in success rate, the
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Tabll 4
Patients' Impression of Response to Surgery
Patient" Impression
1 Increased Function (not persistent)
2* Improved walking (persistent)
3* Overall improvement in function (persistent)
4 Worsening of Underlying Disease
5* Greatly improved function (persistent)
Medication dosage markedly reduced





“ * Responders (at 12 months after surgery).
Table 5
Characteristics of Responders Versus Non-responderf
Characteristic 
at Time o f Surgery
Responders Nonresponders
Age (yr) 51.2 ± 5.9 51.5 ± 3.4
Duration o f disease (yr) 10.0 ± 1.2 10.2 ± 2.2
Hoehn and Yahr rating 3 ± 0.4 2.8 ± 0.3
Daily medication (mg i.-Dopa)'* 1088 ± 153 700 ± 0
Motor score while "o n ” (Unified 17.0 ± 8.7 16.0 ± 6.7
Rating Scale for Parkinson’s
disease
Percentage o f time "o ff ' 32.2 ± 18.8 31.2 ± 12.0
Adrenal gland quality (mm)' 3.25 ± 0.48 3.0 ± 0.41
Unilateral graft “success rate” 3/5 (60%)
Bilateral graft “success rate” 1/3 (33%)
“ All values are mean ± SE.
h Difference in medication was the only suggestive factor. 
‘ W idth o f medullary ribbon.
characteristics of the unilateral and bilateral graft recipients 
were compared (Table 6). No significant differences were 
noted, except that bilateral graft recipients were receiving less 
medication preoperatively.
Imaging and spinal fluid assessments
Imaging assessment with the position of the coils main­
tained consistently for up to 18 months of follow-up showed 
no unusual alteration in structure. In particular, no alteration 
in dye contrast studies was noted.
SPECT studies were performed on the initial 5 patients 
during the postoperative period. All studies were negative, 
with the exception of that of Patient 5, who showed transient 
activity indicative of blood-brain barrier alteration in the 
region of his right basal ganglia 1 month after surgery.
Periodic assessment of lumbar spinal fluid catecholamines 
failed to disclose a pattern of alteration.
Netirops\rliological testing
No patterns of improvement or worsening could be dem­
onstrated in the neuropsychological test battery. The two 
patients (Patients 4 and 6) who felt subjectively improved in 
their cognitive function did show the greatest improvement 
across all their test scores; however, this was not statistically 
significant.
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Tuui 6
Characteristics of Patients with Cnilutcral versus Those with Bilateral Grafts"
Unilateral Bilateral
Age (yr) 50.6 52.7 ± 3.7
Duration o f Sy mptoms (yr) 8.6 ± 1.5 12.7 ± 1.1
Hoehn and Yahr rating 2.8 ± 0.42 3.0 ± 0
Medication (mg i.-Dopa)' 1010 ± 159 700 ± 0
Motor score while "on " (Unified Rating Scale for Parkin­ 16.2 ± 4.0 17.0 ± 3.5
son's disease)
Percentage o f time "ofl" 32.5 ± 16.3 29.2 ± 14.5
Adrenal gland quality (mm)' 3.0 ± 0.3 3.3 ± 0.7
" All values are mean ± SF..
h Difference in medication was the only suggestive factor. 
' W idth of medullary ribbon.
REPRESENTATIVE CASE HISTORIES
Patient 1 (Nonrespo'uier/
This 43-year-old. right-handed man developed neurological symp­
toms at the age o f 33. He was previously employed as a carpet layer 
but stopped working at age 37 because o f the progression of his 
disease despite increasing doses o f medication. His initial symptoms 
were tremor and rigidity of his right arm. Several years later, he 
developed bradvkinesia and tremor on the left side. His symptoms 
progressed to involve both lower extremities, with rigidity and slow­
ness of movement being the prominent complaints. More recently, 
he developed difficulties with hypophonia.
During the year prior to surgery, he took Sinemet 25-100 (7 pills 
per day) and amantadine (100 mg per day). The therapeutic window 
of his medication was approximately 2.0 hours. During his peak 
function after medication, he was independently ambulatory but 
suffered from dyskinesia involving involuntary' head movements. At 
the end of his effective medication period he suffered from rapid 
wearing off of the medication, during which time his bradvkinesia 
and tremor would return over a period of approximately 15 minutes. 
During his " o f f  periods, his voice was reduced to a barely audible 
whisper and his walking was impaired.
Neurological examination preoperatively during the “o f f  period 
was notable for severe bradvkinesia. hypophonia, moderate rigidity, 
and mild tremor. His signs were worse on the right than on the left 
side. He also demonstrated postural instability.
In July 1987, the patient underwent left adrenalectomy and left 
caudate adrenostriatal autogralt. The left caudate was chosen as a 
target because of predominantly right-sided symptoms. A preopcra- 
tive medication schedule w'as prescribed, but on ihe second day after 
surgery, the patient was noted to have choreiform movements of the 
hands and head. On the third day after surgery, his medication 
schedule was reduced to two 25-100 tablets per day because of 
dystonic movements. His medication was gradually increased as his 
activity increased, reaching his preoperative level on the eleventh day 
after surgery. His response to Sinemet and his neurological exami­
nation was comparable to his preoperative baseline status.
Subsequently, the patient showed transitory improvement in terms 
of rigidity, bradvkinesia. and normal postural reflexes. M ild dyski­
nesia necessitated a reduction in Sinemet. which was further reduced 
in the first 4 to 6 months. The symptoms and signs worsened at 6 
monihs. but then showed a period of improvement. At 20 months 
after surgery, he was found to be independent in all activities of daily 
living, but had independently escalated his dosage of Sinemet to 5 
25-250 tablets per day with "on" periods lasting 3 hours. At this time 
he felt that his overall level of function was worse than his preoperative 
level.
Patient J  (responder/
The patient is a 57-year-old. right-handed businessman in whom 
tremor in the left arm and leg developed at age 44. One year later.
after tremor developed in his right arm, his symptoms were diagnosed 
as Parkinsonism. Levodopa therapy was prescribed, and then Sinemet 
therapy , but his sy mptoms progressed over the next 5 years. In 1983. 
he had a drug ‘'holiday’' without apparent benefit. Bromocriptine was 
tried and discontinued because of side effects. For the 2 years prior 
lo surgery, the patient’s medication regimen had been stable, consist­
ing o f Sinemet 25-250 (5 tablets per day) and trihexyphenidyl (Artane; 
Lederle. Wayne. New Jersey) (2-mg tablets. 3 times per day). The 
patient’s main complaint continued to be tremor, which was signifi­
cantly reduced to 45-60 minutes after he took Sinemet. The effect of 
the drug was variable, ranging from 15 minutes to 2 hours. At the 
peak effect time, tremor was absent, dyskinesia was prominent, and 
hallucinations were occasionally present.
Neurological examination revealed high-amplitude. low-frequency 
rest tremor present bilaterally. Only mild cogwheeling and rigidity 
were present, and the postural reflexes were intact.
The patient underwent left adrenalectomy with grafting o f adrenal 
medullary tissue into the right striatum in September 1987. Imme­
diately after surgery, he demonstrated no tremor, and he required no 
medication during the first day after surgery. His medication was 
gradually increased, and he was discharged on the sixth day after 
surgery with a prescription for the preoperative medication dosage. 
Three weeks after surgery he again noted subjective improvement, in 
that the medication seemed to be taking effect more rapidly and with 
a longer duration action. His drug dosage and the results of exami­
nation remained unchanged at that time. By 6 weeks after surgery, 
Sinemet took effect 15 to 45 minutes after the medication was taken 
and lasted for 3 to 5 hours (preoperative duration, 1-2 hours). The 
dosage of Sinemet was gradually reduced. At 4 months after surgery 
he was taking a total o f 800 mg o f levodopa. as compared with 1250 
mg before surgery. Artane therapy was discontinued for a time. Artane 
was later retried w ithout success, and ethopropazine (Parsidol: Parkc- 
Davis, Morris Plains. New Jersey) has been given, with good tremor 
reduction. At 18 months after surgery . Ihe patient's Sinemel require­
ments reached a plateau at 1000 mg o f levodopa per day.
Patient 5 (responder)
The patient is a 44-year-old. right-handed carpenter whose symp­
toms began I 1 years before admission. His first symptom was diffi­
culty in initiating movement with his right hand. His symptoms 
progressed. Seven years before surgery, his symptoms were diagnosed 
as Parkinson’s disease, and he began taking Sinemet. Fie had a 
progressive increase in his bradvkinesia. with postural instability and 
frequent falls, but w ithout tremor. Medication became dccreasingly 
effective, with sudden "o fT  episodes alternating with severe dyski­
nesia. At the time o f surgery, he was taking Sinemet 25-100 (5.5 
tablets per day), bromocriptine (2.5 mg 4 times per day), and benz- 
tropine (Cogentin: Merck Sharp & Dohmc) (1 tablet 3 times per day). 
The medication effect lasted 2 hours. When "on." he was able to 
ambulate independently but slowly. When “off." he could not rise 
from a chair or bed and was unable to stand or walk.
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In November 1987. lie underwent left adrenalectomy and place­
ment of bilateral adrenostriatal autografts. (Bilateral grafting was 
chosen because of the bilateral nature of his symptoms.) His general 
postoperative course was uneventful. He was discharged on the fifth 
day after surgery with a prescription o f 4 tablets o f Sinemel 25-100 
per day. but bromocriptine therapy was stopped. His neurological 
function at the time was subjectively unchanged and. with regard lo 
motor performance, equal to his preoperative condition.
At 4 weeks after surgery, he reported walking 2 to 3 miles per day, 
compared with one-quarter mile per day before surgery. His freezing 
episodes and falling had abated. He was able to carry on activities 
that were impossible during the previous 2 years. Dyskinesia was a 
prominent finding at his follow-up examination, and therefore, the 
dosage of Sinemet was reduced. The 3-month follow-up revealed 
improved postural stability. Medication requirements were reduced 
further, and at 16 months alter surgery, he required 2 Sinemet 10­
100 tablets per day. Each dose was effective for 3 to 4 hours and 
dyskinesia w'as minimal.
Patient 6 (responder)
This 65-ycar-old right-handed, retired finance executive developed 
Parkinson's disease 7 years before surgery. Tremor of the left hand 
and dragging o f the left foot were the initial symptoms. Bradykinesia 
progressed, in spite o f multiple medication changes, and he experi­
enced frequent falls. A drug holiday temporarily improved his symp­
toms. Immediately before surgery, he was taking up to 1000 mg o f 
levodopa and 10 mg o f bromocriptine per day. Additionally, he took 
clonazepam for insomnia. He was wheelchair dependent, and re­
quired assistance in all his activities. Neurological examination re­
vealed significant hypophonia. masklike facies, rigidity, and bradyk­
inesia. His postural reflexes were completely absent.
The patient underwent adrenal medullary grafting to the right 
caudate nucleus in December 1987. Two days after surgery, he 
experienced severe paranoia, visual hallucinations, and agitation. All 
dopaminergic agents were discontinued, and he experienced severe 
rigidity. The hallucinations abated after 48 hours and had completely 
disappeared by the fifth day. Sinemet 10-100 was slowly reintroduced, 
but on 4 doses per day he could not turn at night and slept only 1 to 
2 hours. Sinemet 25-250 was started, and bromocriptine was cau­
tiously added, but was then discontinued because of priapism. He 
was discharged on the tenth day after surgery.
Four weeks after surgery, the patient was taking Sinemet 25-100 4 
times per day. His walking was improved. He used a walker, and on 
one occasion walked independently. His ability to sleep was impaired, 
necessitating the continued use o f clonazepam.
Eight weeks after surgery, he was more mobile and independent in 
self-care, and was able to turn in bed at night. His postural reflexes 
had normalized, and he stopped using a walker. His Sinemet require­
ments gradually increased, however. Depression ensued and am itrip­
tyline was added. He continued to function well until 11 months 
after surgery , when he developed a reactive depression and took an 
overdose of clonazepam and amitriptyline. Sinemet was withheld in 
the intensive care unit for 1 week, and then restarted at 25-250 3 
times per day. along with bromocriptine. His examination 16 months 
after surgery continued to show improvement in bradykinesia. pos­
tural reflexes and gait. Falls and freezing had returned, however, and 
he resumed the use of a walker. He is being treated with fluoxctene 
(Prozac: Lilly. Indianapolis, Indiana) and amitriptyline for his depres­
sion and sleep disorder.
Patient 10 (Death)
A 50-year-old. right-handed. Korean man developed Parkinson's 
disease at age 37. He had a degree in English from a Korean University 
and operated a health food store in the United States until his disease 
developed.
In 1978. he began taking Sinemet. with good results. After his 
symptoms progressed, a drug holiday was tried, with some effect.
Bromocriptine therapy has been tried and discontinued because of 
lack o f benefit. The patient's Sinemet requirements before surgery 
were 900 mg o f levodopa. Fie had significant peak dose dyskinesia 
lhat was very uncomfortable after taking each pill. He was unable to 
turn at night. Freezing episodes and falls were troublesome, and he 
was wheelchair bound while "off." lie  spent most of the day "oflT." 
with only 3 to 4 hours of “on" time per day. Ilis examination revealed 
severe rigidity and bradykinesia. but no tremor. He was unable to 
walk unassisted.
lie underwent left adrenalectomy and bilateral grafting of adrenal 
medulla into the corpus striatum in May 1988. Postoperativcly. he 
was “ofl" most o f the time and bedridden. At the time of adrenalec­
tomy. he was found to have renal stones with hydronephrosis. A 
lithotripsy procedure was planned after discharge.
He was discharged with a prescription of Sinemet 25-100 ( 8 tablets 
per day). Four weeks alter surgery, the family felt that he was very 
depressed and unmotivated. His examination, which showed no 
changes from his baseline, revealed severe hypophonia and bradyki­
nesia and moderately increased tone. The patient was confined to a 
wheelchair. There was no tremor.
Six weeks after surgery, he underwent lithotripsy under general 
anesthesia. Cardiac arrest occurred during the procedure. Efforts at 
resuscitation failed. Examination o f the patient's brain demonstrated 
both gross and histological findings of Parkinson's disease, and 
showed that the coils had entered the caudate head near the lateral 
angle o f the lateral ventricle (Fig. 8). Tissue harvested from the coils 
showed minute foci o f closely aggregated cells with dusky cytoplasm 
and relatively large round and regular nuclei, numbering no more 
than 50 cells per cluster, having the appearance of adrenal medulla. 
These areas formed a small percentage (5-10%) o f the tissue having 
the appearance o f adrenal gland (Fig. 9).
DISCUSSION
The concept of grafting tissue into the nervous system will 
cclcbrate its centennial in 1990 (46). One of the earliest 
experimental landmarks, and of considerable relevance to 
recent events in clinical neuroscience, was the study reported 
by Elizabeth Dunn in 1917 (46). She grafted cerebral cortex 
from embryonic rats into cavities of litter-matc hosts and 
noted that the hosts survived whenever the grafts were juxta­
posed to the choroid plexus of the lateral ventricles. She also 
noted retention of the organotypic appearance of the grafted 
cortex, which, along with observed survival, remains one of 
the hallmark principles in the field. In 1957, Flerko and 
Szentagothai (17) reconfirmed these observations in neurocn-
F ig . 8. Coronal section o f the ccrebral hemispheres through the 
anterior striatum with the corpus callosum and medial hemispheres 
removed. Note placement of the coils and the clean immediate 
surrounding area.
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FlCi. 9. low-power view o f tissues from the middle portion o f 
the coil. Sharply matginaied clear zones are collapsed profiles created 
by the wire. Organized fibrous connective tissues surround these 
areas. Arrowhead points to a small island o f dark-staining surviving 
medullary cells. The immediately adjacent palcr-staimng tissues on 
both sides are remnants o f adrenal cortex (Verhoelfs elastic tissue 
stain and van Gieson stain. >03) Ii. cluster o f surviving darker- 
staining medullary cells surrounded by remnants or adrenal cortex 
(VerhocfTs elastic tissue stain and van Gieson stain. x450).
docrinological experiments in which tissues were placed in 
the third ventricle, where excellent survival was noted. Res­
toration ol'endocrine function has subsequently been shown, 
thus demonstrating the first evidence o f functional interaction 
between grafted tissue and host brain (46). Experimentation 
progressed to demonstrate viability o f cells, integration into 
host brain, and evidence o f functional restoration in several 
rodent and primate models through the past two decades (3.
7. X. 18. 46). These reports have stimulated exploration into 
the clinical sector initially by Backlund ct al. (4) and then by 
Madra/o et al. (34), in efforts to apply key and promising 
observations in the laboratory sector lo Parkinsonian humans. 
These reports have initiated many parallel investigations, 
several rcccnt reports, and intense discussion.
The study reported here was designed to combine concepts 
elaborated during established laboratory observations and an 
amalgam of surgical techniques described by both the Back­
lund and Madra/o groups. A consistent volume o f histologi­
cally defined adrenal medullary tissue was stereotactically 
placed in the caudate head and striatum with periependymal 
and cerebrospinal fluid access. Early reports and more recent 
experiences o f other investigators using conventional crani­
otomy for striatal exposures called for caution regarding fre­
quent multiple complications related lo the central nervous.
cardiac, pulmonary, and gastrointestinal systems(24: personal 
communications: Bakay R. April 1989: Madrazo I. April 
1489: Robertson J. June 1988). Our approach was to select a 
group of patients by a rigorous screening technique to assure 
m inimum  surgical risk and to m inim i/e the trauma of the 
procedure. Safety and standardization of the procedure were 
achieved in two respects: first, by employing a retroperitoneal 
surgical method for harvesting the adrenal tissue, visceral 
retraction and handling was reduced: second, by employing a 
stereotactic method for tissue grafting, important advantages 
over craniotomy were gained, because virtually any intracra­
nial location could be accesscd. trauma was minimized, and 
standardization o f reproducible placement with reduction of 
secondary “lesion" effccts could be achieved. Our experiences 
with intraventricular surgery convinced us that surgical vari­
ables and potential ancillary trauma would not only increase 
the risk and surgical magnitude of graft placement, but might 
also complicate interpretation of functional outcome. In ad­
dition. bilateral graft placement could be accomplished with 
little added risk to the patient. In concert with (his approach, 
gland handling and tissue dissection were undertaken with 
care to insure maximum purity and viability of grafted tissue. 
An effort was made to separate adrenal cortical tissue, in part 
because in vitro studies have indicated that the presence of 
cortisol may suppress the tendency of adrenal medullary cells 
to assume neuronal morphology and function when exposed 
to endogenous central nervous system substances such as 
nerve growih factor (12. 13. 48).
Patient selection proved to be a difficult and tedious, with 
only one in eight Parkinsonian individuals considered to meet 
the criteria established for candidacy. O f particular concern 
was identification o f the psvchosocially stable individual w ho 
would be reliable in follow-up. despite potentially difficult 
emotional periods. Care was taken to all'ord patients'anonym­
ity in relation to local and national news media, which pro­
vided a potential for exacerbation of secondary placebo elTects 
on clinical courses, particularly during early periods of obser­
vation.
Although our initial laboratory dissections o f postmortem 
medullary tissue indicated that variability in donor tissues 
would be a problem, this provided significant difficulty in one 
case, which precluded grafting. There was no absolute rela­
tionship between the patient's age and adrenal tissue quality. 
We feci that the inconsistency of donor tissue and risk o f the 
adrenalectomy should encourage efforts to investigate alter­
nate donor sources. Such sources include: autologous para- 
neurons. cadavcr adrenal or parancurons. fetal mcsenceph- 
alon or adrenal, as well as altered neuroblastoma or genetically 
engineered cells, all in banked form (46. 49). Aside from 
ethical and certain scientific difficulties, fetal tissue would 
appear to be the current logical choicc. Genetically engineered 
and immortalized cell lines represent possible future consid­
erations (44). Ccll dispersion techniques may increase ulti­
mate sustained viability of grafted tissues.
Although the low- morbidity associated with our procedure 
was an outcome related to numerous factors, the advantages 
of stereotactic methods for ccrebral grafting are readily appar­
ent. as they enhance the precision, safety, reproducibility and 
options o f graft placement (24. 43. and personal communi­
cations: Backlund E-0. April 1989: Bakay R. April 1989. 
Vladrazo I. April 1989). The availability o f banked tissue 
when combined with stereotactic techniques would signifi­
cantly reduce morbidity and increase options with respect to 
graft-host interactions, it is our belief that the standardization 
afforded by the stereotactic method clearly reduced variables 
attendant on outcome in comparison with the open surgical 
method.
Postoperative observations indicated both objective and 
subjective initial improvement in 4 of the 8 patients who 
received grafts. Although any definition of response short of 
cure may be arguable. 4 of the 8 patients demonstrated 
sustained reduction of medication requirements combined 
with improvement in motor performance scores for periods 
of 16 to 20 months, and stated that they considered to have 
benefited from the procedure. Placebo effect may be operant 
during the early postoperative period; however, it is doubtful 
that a placebo effect would be sustained for more than 12 
months. This data would indicate a need for further study of 
variations of this procedure, including alternative graft tissue 
sources, studies of graft-host interactions, and local environ­
mental factors such as growth factors (e.g.. nerve growth 
factor, fibroblast growth factor, etc.) and endogenous toxins 
(e.g., excitatory am ino acids) (31. 37. 44. 48). It is important 
that improvement in techniques and methods be applied to 
individuals who have participated in these early exploratory 
studies and. therefore, they will not be excluded from further 
developments in the field.
Issues of mechanisms of effect and patient selection remain 
enigmatic areas. No clear-cut “ responder profile" was appar­
ent. nor was benefit from bilateral placement of graft tissue 
noted. From the experiences of others, it would appear that 
end-stage Parkinsonian patients are not candidates for this 
approach (personal communications: Backlund F.-O. April 
1989; Bakay R. April 1989; Madrazo I. April 1989; Robertson 
J. June 1988); however, our group of moderately to severely 
disabled patients indicates that the approach may be appli­
cable to a significant number of Parkinsonian patients, and 
that our inclusion criteria may be excluding individuals who 
could experience benefit.
A number of potential mechanisms could theoretically 
contribute to the clinical changes observed in these patients 
(9, 10. 16, 38);
1. The production and release of dopamine by chromaffin 
cells into the surrounding striatum. Potential arguments 
against this mechanism include;
a. The 3- to 5-month delay in maximal clinical improve­
ment. Animal models indicate that stable medullary cells 
should produce usable catecholamines during the period 
immediately after transplantation.
b. No increase in cerebrospinal fluid catecholamine levels 
were observed; however, this docs not necessarily ex­
clude local effects within the striatum.
c. The paucity o f viable medullary cells on postmortem 
examination.
d. The observation that unilateral grafts are followed by 
bilateral functional improvements.
2. The effect o f the surgical lesion on the striatum. In 
primates treated with MPTP (1 -niethyl-4-phenyl-1.2.3.6-tet- 
rahydropvridine. placement o f a silver tissue carrier into the 
striatum alone without tissue has been shown to result in 
increased sprouting of host fiber (18). Neurite-promoting 
activity has been shown to peak 1 to 2 weeks after brain 
injury (41). Such sprouting in response to injury and release 
of trophic factor could then lead to enhanced activity of 
physiological circuits within the striatum.
3. The inductive effect of grafted tissue. Adrenal medullary 
grafts have been shown to enhance recovery of striatal dopa­
mine fibers after injury (12). The reasons for these regenera­
tive effects are not known, but we might speculate that grafted 
tissue may induce recovery by providing or releasing trophic 
influences on damaged host neurons. Sprouting by host neu­
rons in response to grafted cells has been shown in animals
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to occur over a longer period of time, which could correlate 
with the improvement observed over several months in our 
patients.
4. Vascular alternatives. Breakdown of the blood-brain 
barrier could lead to more effective delivery of therapeutic 
drugs to the striatum. Arguments against this mechanism 
include:
a. The integrity of the blood-brain barrier in the region of 
the graft in all but 1 patient, as shown postoperatively 
on SPECT scanning.
b. The delay in onset of improvement. It would be expected 
that the blood-brain barrier would be maximally dis­
rupted immediately after surgery, although delayed al­
terations in blood-brain barrier could also occur.
5. A placebo effect.
6. The complexity of grafted tissue. The adrenal tissue 
transplanted is not homogenous; a variety of cell types, in­
cluding corticotrophs, chromaffin cells, and connective and 
vascular elements are present in the adrenal tissue. Studies in 
primates indicate that there is minimal survival of adrenal 
chromaffin cells 1 month after transplantation (18). There 
are, however, large numbers of macrophages. The potential 
effects of these cells in the brain is unknown. In our postmor­
tem examination, a mixed population of cells including cor­
ticotrophs and chromaffin cells was seen.
Our findings and other data would appear to indicate that 
the biological "pum p” concept is most likely a simplification 
of a complex concatenation of biological events attendant on 
clinical changes in primate models and responder patients. 
The definition of these complex mechanisms and elucidation 
of the reality of the potential for grafting as a therapeutic 
mode for restoration of central nervous function will require 
many careful studies in both the laboratory and clinical 
sectors.
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OBSERVATION SU M M A RY
The primary observations of this study were as follows:
1. The available adrenal medullary donor material was of 
variable quality and occasionally inadequate.
2. Stereotactic placement of graft donor tissue was reliably 
and safely accomplished in a consistent and reproducible 
fashion.
3. Surgical complications were minimal, provided that care 
in selection and technique as described herein were 
followed.
4. Seven of eight showed evidence of clinical improvement 
during early (6 months) periods of observation.
5. Four of eight patients demonstrated sustained (>1 year) 
alterations in the patterns of their clinical disorders, with 
improvement in clinical parameters being observed over 
a period of 16 to 20 months.
6. The onset of these favorable patterns varied within 12 
weeks after surgery .
7. No characterization of a responder profile was evident.
8. No advantage to bilateral grafting was noted.
9. Autopsy findings in a clinical nonresponder 6 weeks 
after surgery demonstrated a mixed cellular population 
in which 5% of the cells at the graft site consisted of 
structurally preserved medullary cells.
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CONCLUSIONS
Primary conclusions based on the observations, experi­
ences. and data of this study are as follows:
1. Stereotactic technique offers a consistently uniform, re­
producible. minimally invasive, safe method for cerebral 
grafting and requires consideration in future clinical 
studies related to this concept.
2. Sustained modest clinical improvement may be ex­
pected in a some Parkinsonian patients when this 
method is employed.
3. The mechanisms responsible for these changes are not 
clearly apparent, but may not relate to the biological 
quality or quantity of grafted tissue.
4. Further clinical studies to evaluate the impact of grafts 
on central nervous system function arc indicated.
5. Studies related to the employment of banked forms of 
tissue are indicated, and aside from reducing the overall 
trauma attendant on such surgery, may provide im ­
provement in patient response.
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CO M M ENT
Standing alone, this study of adrenal transplantation does
not settle any of the major issues in the field. No statistical
analysis o f the results ofsureerv is provided, and patients are
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grouped retrospectively into responders and nonresponders, 
a dubious procedure. When the results of this study by Apuzzo 
et al. are added to those of other clinical studies, however, a 
number of important observations can be made:
1. The response is variable. Some patients show moderate 
improvement, a few, dramatic improvement (Madrazo's 
initial two cases. Apuzzo's Case 5). and others, little to 
no change.
2. The improvement, when it occurs, is weeks to months 
after the operation and lasts at least a year in most 
patients.
3. Unilateral operations implanting a graft in only one 
caudate may result in bilateral motor improvement.
4. The morbidity and mortality of the operations are sub­
stantial in some series, but are less when stereotaxic 
implants and a retroperitoneal approach are used.
The authors' thoughtfully designed and carefully executed 
study using uniform and well-accepted measures of Parkin­
son's disease leads to similar observations. There was no 
significant morbidity and mortality using the stereotaxic and 
retroperitoneal approaches; motor responses occur several 
months after the operation and are sustained up to 16 months; 
and a unilateral implant has the same bilateral motor effects 
as a bilateral implant.
Although a pattern of change after adrenal implant appears 
to be established, which operative procedure is best remains 
undecided. Apuzzo et al. argue that the stereotaxic approach 
is advantageous. Certainly, there is no denying that it is easier 
and safer, but we simply do not have evidence that it is more 
effective. A study comparing open and stereotaxic procedures 
has yet to be performed. Until this is done, doubt about the 
effectiveness of the stereotaxic procedure remains. The initial 
Swedish implants were done stereotactically and were without 
significant clinical effect. The Madrazo open procedure, in 
which there was more transplanted tissue, an injury to the 
caudate, and exposure of the graft to cerebrospinal fluid, 
provided the first positive results. These results have been 
confirmed by a multicenter study, although the changes were 
much less dramatic. Is the the open procedure's greater injury 
to the cortex and caudate important in creating the improve­
ments?
This raises the pivotal question: Why does the procedure 
have any effect whatsoever? The authors mention the current 
theories. Biological pumps for dopamine are unlikely, and 
neurotrophic factors induced by the trauma of surgery, the 
metal carrier, inflammatory cells, or other non-medullary cells 
are all possibilities. Which factor or factors are important will 
be difficult to resolve because of the difference between animal 
models and human disease. Animal models have already been 
misleading. Extrapolation from animal implants suggested 
that dopamine could be replaced by grafting, and led to the 
first transplants. Now we know most of the adrenal medullary 
cells in humans die, no increase in dopamine production is 
found, and the effects are bilateral, so other factors must 
account for clinical changes. Until we have some solid clues 
about these factors, new operations will be difficult to design 
rationally. For the present, the best that can be done is to 
report results in a clear and standardized manner, as Apuzzo 
et al. have done, so that, gradually, an empirically proven 
procedure will evolve. The science will then have to catch up 
with the clinical procedures.
Richard D. Penn
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